51640-36-9

基本信息
2-氯噻唑-5-甲腈
2-氯-5-噻唑甲腈
2-氯-5-氰基噻唑
2-CHLOROTHIAZOLE-5-CARBONITRILE
2-chloro-5-thiazolecarbonitrile
5-Thiazolecarbonitrile, 2-chloro-
2-Chlorothiazole-5-carbonitrile 97%
2-CHLORO-1,3-THIAZOLE-5-CARBONITRILE
2-Chlorothiazole-5-carbonitrile ,97%
2-CHLOROTHIAZOLE-5-CARBONITRILE, 95+%
2-CHLOROTHIAZOLE-5-CARBONITRILE,2-CHLORO-5-THIAZOLE CARBONITRILE
物理化學(xué)性質(zhì)
制備方法

51640-52-9

51640-36-9
以2-氨基-5-氰基噻唑為起始原料合成2-氯噻唑-5-甲腈的一般步驟:將3.4 g(27 mmol)2-氨基-5-氰基噻唑(實施例43)與5.1 g(30 mmol)二水合氯化銅均勻分散于100 mL乙腈中。在劇烈攪拌條件下,于30分鐘內(nèi)緩慢滴加5.7 mL亞硝酸異戊酯的乙腈溶液,滴加完畢后繼續(xù)反應(yīng)10小時。反應(yīng)完成后,將反應(yīng)混合物濃縮,殘余物溶解于乙酸乙酯中,過濾去除不溶性雜質(zhì)。濃縮有機相,通過柱色譜法進行純化,得到2.6 g目標產(chǎn)物(收率67%),為液體。該液體靜置后可析出針狀結(jié)晶,熔點為54-57℃。13C NMR(CDCl3,ppm)數(shù)據(jù)如下:108.16, 110.41, 150.59, 157.36;質(zhì)譜(EI)顯示分子離子峰m/z為144.1(M+)。
參考文獻:
[1] Journal of Medicinal Chemistry, 2004, vol. 47, # 25, p. 6363 - 6372
[2] Patent: EP2039686, 2009, A1. Location in patent: Page/Page column 32-33
[3] Patent: US2010/87448, 2010, A1. Location in patent: Page/Page column 22
[4] Patent: US2004/23978, 2004, A1. Location in patent: Page/Page column 13
[5] Patent: US2004/23980, 2004, A1. Location in patent: Page/Page column 13